Title: Randomised Clinical Trials in pharmacy practice
Overview: The highest level of evidence for healthcare interventions is still the randomized clinical trial. Originally designed for ‘technological’ interventions such as new drugs or surgical procedures, the RCT has also become the standard to evaluate cognitive pharmacy services (CPS). These type of care interventions are often complex and available research funding is not anywhere near the budgets of the pharmaceutical industry. Thus pharmacists and researchers face several challenges. They have to design clever interventions that can are feasible in daily pharmacy practice and can be monitored without clinical research associates flying in and out all week. Moreover sufficient numbers of patients have to be included and these patients should be likely to benefit from an intervention. Finally we have to choose outcomes that are sensitive to change and have sufficient clinical relevance. It is clear that challenges are big and many researchers have had frustrations performing these. In this lecture I will give examples and hope to inspire colleagues to bring pharmacy practice research a few steps further.
CV: Prof. Marcel L Bouvy (1966) obtained his PharmD at Groningen University in 1992 and his PhD at Utrecht University in 2002. In 2009 he was appointed as professor of pharmaceutical care at the department of Pharmacoepidemiology and Clinical Pharmacology at Utrecht university. In this function he is chair of the Utrecht Pharmacy Panel for Education and Research (UPPER), which coordinates all internships and pharmacy practice research. Moreover, Marcel has been an active community pharmacist since 1992 and works at SIR institute for Pharmacy Practice and Policy in Leiden which closely cooperates with Utrecht University. Since 2016 he is member of the Dutch Medicines Evaluation Board.
Marcel is active in several national and international committees and platforms aiming to improve the safe and effective use of medicines. He is past president of the research committee of ESCP, past president of the Scientific Section of Dutch Community Pharmacists (WSO), founding member of the European Society for Patient Adherence, Compliance and Persistence (ESPACOMP) and member of the editorial board of the International Journal for Pharmacy Practice.
Marcel research activities focus on patient adherence, medication safety and include both observational work and evaluation of innovative pharmacy interventions. Marcel is (co-)author of >300 papers in peer reviewed and national pharmacy journals, both professional and consumer oriented book (chapters) on medicines and research reports.